Abeona Therapeutics Inc

Market cap: $114,891,155

Exchange: NAS

Sector: Health Technology

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

STOCK PRICE CHART

Key Statistics

Company Name

Abeona Therapeutics Inc

Average Volume (10 days)

1,344,857

Average Volume (30 days)

1,357,175

Moving Average (50 days)

$6.04

Moving Average (200 days)

$5.62

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

Market Cap

114,891,155

Shares Outstanding

27,355,037

52-Week High Split Adjust Only

9.01

52-Week Low Split Adjust Only

2.83

Employee Count

Beta

0.2423

Next Earnings Date

TTM Dividend Rate Per Share

Price Changes

Past 5 days

-0.09%

Past 30 days

-0.46%

Past 3 months

-0.32%

Past 6 months

0.03%

Past year

0.41%

Past 2 years

29.77%

Past 5 years

-0.45%

Max % Change

-0.41%

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
Abeona Therapeutics Inc	ABEO	n/a	n/a	-2.4	n/a	n/a
Peer Avg	N/A	1.00	1.78	2.9	1.00	1.13
Merck & Co Inc	MRK	4.00	7.13	11.7	4.00	4.51
Taro Pharmaceutical Industries	TARO	n/a	n/a	n/a	n/a	n/a